| Antiviral potentials of medicinal plants M Mukhtar, M Arshad, M Ahmad, RJ Pomerantz, B Wigdahl, Z Parveen Virus research 131 (2), 111-120, 2008 | 479 | 2008 |
| Cellular reservoirs of HIV-1 and their role in viral persistence A Alexaki, Y Liu, B Wigdahl Current HIV research 6 (5), 388-400, 2008 | 464 | 2008 |
| CD4-independent infection of human neural cells by human immunodeficiency virus type 1 JM Harouse, C Kunsch, HT Hartle, MA Laughlin, JA Hoxie, B Wigdahl, ... Journal of virology 63 (6), 2527-2533, 1989 | 364 | 1989 |
| Breaking down the barrier: the effects of HIV-1 on the blood–brain barrier M Strazza, V Pirrone, B Wigdahl, MR Nonnemacher Brain research 1399, 96-115, 2011 | 261 | 2011 |
| HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination A Alexaki, B Wigdahl PLoS pathogens 4 (12), e1000215, 2008 | 182 | 2008 |
| Immunological control of herpes simplex virus infections KP Egan, S Wu, B Wigdahl, SR Jennings Journal of neurovirology 19, 328-345, 2013 | 161 | 2013 |
| The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1 V Pirrone, B Wigdahl, FC Krebs Antiviral research 90 (3), 168-182, 2011 | 146 | 2011 |
| Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration K Barmak, E Harhaj, C Grant, T Alefantis, B Wigdahl Virology 308 (1), 1-12, 2003 | 146 | 2003 |
| A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses MK Howett, EB Neely, ND Christensen, B Wigdahl, FC Krebs, D Malamud, ... Antimicrobial agents and chemotherapy 43 (2), 314-321, 1999 | 144 | 1999 |
| Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage EM Kilareski, S Shah, MR Nonnemacher, B Wigdahl Retrovirology 6, 1-24, 2009 | 141 | 2009 |
| Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and … C Grant, K Barmak, T Alefantis, J Yao, S Jacobson, B Wigdahl Journal of cellular physiology 190 (2), 133-159, 2002 | 140 | 2002 |
| Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate FC Krebs, SR Miller, D Malamud, MK Howett, B Wigdahl Antiviral research 43 (3), 157-173, 1999 | 131 | 1999 |
| Combinatorial approaches to the prevention and treatment of HIV-1 infection V Pirrone, N Thakkar, JM Jacobson, B Wigdahl, FC Krebs Antimicrobial agents and chemotherapy 55 (5), 1831-1842, 2011 | 122 | 2011 |
| Animal models of herpes simplex virus immunity and pathogenesis CM Kollias, RB Huneke, B Wigdahl, SR Jennings Journal of neurovirology 21, 8-23, 2015 | 121 | 2015 |
| Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax T Alefantis, K Barmak, EW Harhaj, C Grant, B Wigdahl Journal of Biological Chemistry 278 (24), 21814-21822, 2003 | 118 | 2003 |
| Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1 FC Krebs, SR Miller, ML Ferguson, M Labib, RF Rando, B Wigdahl Biomedicine & pharmacotherapy 59 (8), 438-445, 2005 | 115 | 2005 |
| Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides BJ Catalone, TM Kish-Catalone, LR Budgeon, EB Neely, M Ferguson, ... Antimicrobial agents and chemotherapy 48 (5), 1837-1847, 2004 | 115 | 2004 |
| Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection RD Kensinger, BJ Catalone, FC Krebs, B Wigdahl, CL Schengrund Antimicrobial agents and chemotherapy 48 (5), 1614-1623, 2004 | 109 | 2004 |
| Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes FC Krebs, SR Miller, BJ Catalone, PA Welsh, D Malamud, MK Howett, ... Antimicrobial Agents and Chemotherapy 44 (7), 1954-1960, 2000 | 103 | 2000 |
| HIV-I-associated central nervous system dysfunction FC Krebs, H Ross, J McAllister, B Wigdahl Advances in pharmacology 49, 315-385, 2000 | 101 | 2000 |
